23 studies found for:    Reye's Syndrome
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Intracranial Hypertension and Optic Nerve Sheath Diameter
Conditions: Cerebral Stroke;   Cerebral Venous Thrombosis
Intervention: Other: ONSD ultrasound
2 Completed Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women
Conditions: Pregestational Obesity (BMI > 27kg/m2);   History of Polycystic Ovary Syndrome
Interventions: Drug: medical nutrition therapy + metformin;   Behavioral: Medical nutrition therapy
3 Recruiting Restless Leg Syndrome and Severe Preeclampsia
Conditions: Restless Leg Syndrome;   Severe Preeclampsia
Intervention:
4 Completed Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge
Conditions: ACS;   Acute Coronary Syndrome;   Myocardial Infarction;   Unstable Angina;   Coronary Artery Disease
Intervention:
5 Terminated Phase III Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Apixaban;   Drug: Placebo
6 Recruiting ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab SAR236553 (REGN727)
Condition: Acute Coronary Syndrome
Interventions: Drug: alirocumab SAR236553 (REGN727);   Other: placebo
7 Completed Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity.
Condition: Respiratory Distress Syndrome, Newborn
Intervention: Procedure: Preterm fetus
8 Completed The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Condition: Acute Coronary Syndrome
Interventions: Drug: Darapladib 160 mg;   Drug: Placebo;   Other: Standard Therapy
9 Completed Colloids in Severe Trauma
Conditions: Abdominal Hypertension;   Abdominal Compartment Syndrome;   Severe Trauma
Intervention: Drug: tetrastarch (Voluven)
10 Completed A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Aleglitazar;   Drug: Placebo
11 Terminated L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia
Condition: Pre-Eclampsia
Interventions: Procedure: L-arginine supplementation in a medical food;   Procedure: Vitamin C and E supplementation in a medical food
12 Unknown  PI Vs. NNRTI Based Therapy for HIV Advanced Disease
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: zidovudine+lamivudine+lopinavir/ritonavir;   Drug: zidovudine + lamivudine + efavirenz
13 Completed Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)
Condition: Prostatic Cancer
Intervention:
14 Not yet recruiting Antiphospholipid Antibodies and Fetal Growth Restriction
Conditions: Fetal Growth Restriction;   Antiphospholipid Syndrome
Intervention:
15 Not yet recruiting Antiphospholipid Antibodies and Early Severe Preeclampsia.
Conditions: Severe Preeclampsia;   Antiphospholipid Syndrome
Intervention:
16 Recruiting Concussion and Post Traumatic Stress in Traumatic Brain Injury
Conditions: Concussion;   Stress Disorders, Post-Traumatic
Intervention:
17 Unknown  6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
Condition: Multiple Organ Dysfunction Syndrome
Intervention: Drug: 6-methyl-prednisolone
18 Recruiting Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia;   Chronic Myelomonocytic Leukemia;   de Novo Myelodysplastic Syndrome;   Previously Treated Myelodysplastic Syndrome
Interventions: Biological: Epoetin Alfa;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide
19 Completed Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo
20 Unknown  Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Condition: Kaposi´s Sarcoma
Intervention: Drug: Bevacizumab

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Indicates status has not been verified in more than two years